{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:45:47Z","timestamp":1787741147340,"version":"build-2784847793"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre, Poland","doi-asserted-by":"publisher","award":["11 2016\/21\/B\/NZ4\/00128"],"award-info":[{"award-number":["11 2016\/21\/B\/NZ4\/00128"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004382","name":"Institute of Pharmacology Polish Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cyto.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T06:36:19Z","timestamp":1555396579000},"page":"202-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia"],"prefix":"10.1016","volume":"119","author":[{"given":"Klaudia","family":"Kwiatkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Popiolek-Barczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Piotrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Rojewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Ciapa\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioletta","family":"Makuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1986-7205","authenticated-orcid":false,"given":"Joanna","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2019.03.007_b0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.lfs.2013.10.005","article-title":"Contribution of macrophages to peripheral neuropathic pain pathogenesis","volume":"93","author":"Ristoiu","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.cyto.2019.03.007_b0010","first-page":"803","article-title":"Neuropathic pain and cytokines: current perspectives","volume":"6","author":"Clark","year":"2013","journal-title":"J. Pain Res."},{"key":"10.1016\/j.cyto.2019.03.007_b0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40122-017-0091-4","article-title":"Pharmacotherapy for neuropathic pain: a review","volume":"6","author":"Fornasari","year":"2017","journal-title":"Pain Ther."},{"key":"10.1016\/j.cyto.2019.03.007_b0020","article-title":"Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness","author":"Mika","year":"2008","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.cyto.2019.03.007_b0025","series-title":"Pain Control","first-page":"145","article-title":"The role of glia in the spinal cord in neuropathic and inflammatory pain","author":"Old","year":"2015"},{"key":"10.1016\/j.cyto.2019.03.007_b0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coph.2011.10.015","article-title":"Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states","volume":"12","author":"Old","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cyto.2019.03.007_b0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.aat.2013.08.006","article-title":"The immune aspect in neuropathic pain: role of chemokines","volume":"51","author":"Liou","year":"2013","journal-title":"Acta Anaesthesiol. Taiwanica."},{"key":"10.1016\/j.cyto.2019.03.007_b0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","article-title":"Chemokines, neuronal-glial interactions, and central processing of neuropathic pain","volume":"126","author":"Gao","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cyto.2019.03.007_b0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coph.2011.10.007","article-title":"Chemokines and cytokines in neuroinflammation leading to neuropathic pain","volume":"12","author":"Kiguchi","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cyto.2019.03.007_b0050","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.pharep.2018.01.006","article-title":"The importance of chemokines in neuropathic pain development and opioid analgesic potency","volume":"70","author":"Kwiatkowski","year":"2018","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.cyto.2019.03.007_b0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jneuroim.2010.05.010","article-title":"The role of monocyte chemoattractant protein MCP1\/CCL2 in neuroinflammatory diseases","volume":"224","author":"Conductier","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cyto.2019.03.007_b0060","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1086\/344266","article-title":"The chemokine system in neuroinflammation: an update","volume":"186","author":"Ransohoff","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2019.03.007_b0065","doi-asserted-by":"crossref","first-page":"12396","DOI":"10.1523\/JNEUROSCI.3016-07.2007","article-title":"Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cyto.2019.03.007_b0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jneuroim.2016.04.017","article-title":"Direct and indirect pharmacological modulation of CCL2\/CCR2 pathway results in attenuation of neuropathic pain \u2013 in vivo and in vitro evidence","volume":"297","author":"Piotrowska","year":"2016","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cyto.2019.03.007_b0075","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11481-017-9729-6","article-title":"The RS504393 influences the level of nociceptive factors and enhances opioid analgesic potency in neuropathic rats","volume":"12","author":"Kwiatkowski","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.cyto.2019.03.007_b0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2014.12.043","article-title":"MCP-1 stimulates spinal microglia via PI3K\/Akt pathway in bone cancer pain","volume":"1599","author":"Jin","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.cyto.2019.03.007_b0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pnpbp.2015.07.005","article-title":"Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats","volume":"64","author":"Kwiatkowski","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psych."},{"key":"10.1016\/j.cyto.2019.03.007_b0090","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/WNR.0000000000000625","article-title":"Neuronal-derived Ccl7 drives neuropathic pain by promoting astrocyte proliferation","volume":"27","author":"Ke","year":"2016","journal-title":"Neuroreport"},{"key":"10.1016\/j.cyto.2019.03.007_b0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.185.1.99","article-title":"Murine monocyte chemoattractant protein (MCP)-5: A novel CC chemokine that is a structural and functional homologue of human MCP-1","volume":"185","author":"Sarafi","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2019.03.007_b0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.cyto.2019.03.007_b0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.cyto.2019.03.007_b0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.01.013","article-title":"Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain","volume":"560","author":"Mika","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cyto.2019.03.007_b0115","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1111\/bph.14185","article-title":"Antinociceptive effects of novel histamine H3R and H4R receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse","volume":"3","author":"Popiolek-Barczyk","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cyto.2019.03.007_b0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cyto.2019.03.007_b0125","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fimmu.2018.00494","article-title":"Involvement of macrophage inflammatory protein-1 family members in the development of diabetic neuropathy and their contribution to effectiveness of morphine","volume":"9","author":"Rojewska","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2019.03.007_b0130","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/ALN.0000000000001219","article-title":"Microglial inhibition influences XCL1\/XCR1 expression and causes analgesic effects in a mouse model of diabetic neuropathy","volume":"125","author":"Zychowska","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cyto.2019.03.007_b0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.intimp.2017.09.021","article-title":"Spinal CCL1\/CCR8 signaling interplay as a potential therapeutic target \u2013 evidence from a mouse diabetic neuropathy model","volume":"52","author":"Zychowska","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cyto.2019.03.007_b0140","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/750182","article-title":"The role of some chemokines from the CXC subfamily in a mouse model of diabetic neuropathy","volume":"2015","author":"Zychowska","year":"2015","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.cyto.2019.03.007_b0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/glia.20092","article-title":"A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells","volume":"49","author":"Zawadzka","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.cyto.2019.03.007_b0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuropharm.2016.04.024","article-title":"Maraviroc reduces neuropathic pain through polarization of microglia and astroglia \u2013 evidence from in vivo and in vitro studies","volume":"108","author":"Piotrowska","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cyto.2019.03.007_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2017.00141","article-title":"Comparison of the expression changes after botulinum toxin type A and minocycline administration in lipopolysaccharide-stimulated rat microglial and Astroglial cultures","volume":"7","author":"Piotrowska","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cyto.2019.03.007_b0160","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cyto.2019.03.007_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2014.09.020","article-title":"Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model","author":"Rojewska","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cyto.2019.03.007_b0170","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1073\/pnas.1331358100","article-title":"Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2","volume":"100","author":"Abbadie","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cyto.2019.03.007_b0175","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1523\/JNEUROSCI.3623-08.2009","article-title":"JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain","volume":"29","author":"Gao","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cyto.2019.03.007_b0180","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1523\/JNEUROSCI.0485-09.2009","article-title":"Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain","volume":"29","author":"Jung","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cyto.2019.03.007_b0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fncel.2018.00040","article-title":"Activation of astrocytes and microglial cells and CCL2\/CCR2 upregulation in the dorsolateral and ventrolateral nuclei of periaqueductal gray and rostral ventromedial medulla following different types of sciatic nerve injury","volume":"12","author":"Dubov\u00fd","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.cyto.2019.03.007_b0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2012.04.026","article-title":"Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats","volume":"517","author":"Hu","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cyto.2019.03.007_b0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejpain.2008.04.017","article-title":"CCL2 is a key mediator of microglia activation in neuropathic pain states","volume":"13","author":"Thacker","year":"2009","journal-title":"Eur. J. Pain."},{"key":"10.1016\/j.cyto.2019.03.007_b0200","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1523\/JNEUROSCI.5986-10.2011","article-title":"CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury","author":"Van Steenwinckel","year":"2011","journal-title":"J. Neurosci. 31"},{"key":"10.1016\/j.cyto.2019.03.007_b0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s12013-014-0510-7","article-title":"Analgesic effect of intrathecal administration of chemokine receptor CCR2 antagonist is related to change in spinal NR2B, nNOS, and SIGIRR expression in rat with bone cancer pain","volume":"72","author":"Ren","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.cyto.2019.03.007_b0210","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-4159.2005.03520.x","article-title":"Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and I\u03baB\u03b1 degradation in a stimulus-specific manner in microglia","volume":"96","author":"Nikodemova","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cyto.2019.03.007_b0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2009.09.030","article-title":"Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain","volume":"623","author":"Mika","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cyto.2019.03.007_b0220","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0006-8993(94)91958-5","article-title":"Fluorocitrate and fluoroacetate effects on astrocyte metabolism in vitro","volume":"664","author":"Swanson","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.cyto.2019.03.007_b0225","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-5793(96)01024-1","article-title":"Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3","volume":"395","author":"Key-Sun","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cyto.2019.03.007_b0230","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cyto.2014.06.007","article-title":"The role of CXCL12 and CCL7 chemokines in immune regulation, embryonic development, and tissue regeneration","volume":"69","author":"Cheng","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2019.03.007_b0235","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/brain\/aws330","article-title":"Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain","volume":"136","author":"Imai","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.cyto.2019.03.007_b0240","doi-asserted-by":"crossref","first-page":"42260","DOI":"10.1038\/srep42260","article-title":"Interleukin-1\u03b2 pre-treated bone marrow stromal cells alleviate neuropathic pain through CCL7-mediated inhibition of microglial activation in the spinal cord","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cyto.2019.03.007_b0245","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.1500352","article-title":"Differential roles of chemokines CCL2 and CCL7 in monocytosis and leukocyte migration during West Nile virus infection","volume":"195","author":"Bardina","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2019.03.007_b0250","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/jlb.65.6.744","article-title":"Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats","volume":"65","author":"Yamagami","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2019.03.007_b0255","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fncel.2017.00270","article-title":"Microglia: an Interface between the loss of neuroplasticity and depression","volume":"11","author":"Singhal","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.cyto.2019.03.007_b0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1744-8069-9-57","article-title":"Chemokine expression in peripheral tissues from the Monosodium Iodoacetate model of chronic joint pain","volume":"9","author":"Dawes","year":"2013","journal-title":"Mol. Pain."},{"key":"10.1016\/j.cyto.2019.03.007_b0265","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.joca.2016.11.004","article-title":"Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis","volume":"25","author":"Longobardi","year":"2017","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.cyto.2019.03.007_b0270","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.celrep.2016.04.063","article-title":"Persistent alterations in microglial enhancers in a model of chronic pain","volume":"15","author":"Denk","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cyto.2019.03.007_b0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neuropharm.2013.08.031","article-title":"Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats","volume":"75","author":"Makuch","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cyto.2019.03.007_b0280","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.pain.2008.02.015","article-title":"Interleukin-1alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model","volume":"138","author":"Mika","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.cyto.2019.03.007_b0285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mcn.2015.12.013","article-title":"Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine","volume":"71","author":"Pilat","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.cyto.2019.03.007_b0290","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2015.05.058","article-title":"IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model","volume":"764","author":"Pilat","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cyto.2019.03.007_b0295","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1073\/pnas.102327699","article-title":"Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain","volume":"99","author":"Szabo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2019.03.007_b0300","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2003.10.033","article-title":"Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor","volume":"483","author":"Chen","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cyto.2019.03.007_b0305","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MAJ.0b013e31826a82ce","article-title":"Spinal MCP-1 contributes to the development of morphine antinociceptive tolerance in rats","volume":"344","author":"Zhao","year":"2012","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.cyto.2019.03.007_b0310","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917740233","article-title":"Monoclonal antibodies for chronic pain: a practical review of mechanisms and clinical applications","volume":"13","author":"Yeh","year":"2017","journal-title":"Mol. Pain."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619300845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466619300845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:54:50Z","timestamp":1760907290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466619300845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":62,"alternative-id":["S1043466619300845"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2019.03.007","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}